Psychiatry and Neurology, Neurology · Buffalo, NY
NPI
1134192404
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
100 High St, Buffalo General Hospital
Buffalo, NY, 14203
Phone (716) 859-2859
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
10,763 services
Medicare patients, 2024
95
Average age 73
Drug cost, 2024
$299K
2,346 prescriptions
Company payments, 2025
$235
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas Guttuso was code J0585 (injection, onabotulinumtoxina, 1 unit), 10,401 times for 16 patients. In total Thomas Guttuso billed 10,763 services in 20 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 10,401 | 16 | $4.48 | $47K |
| 99214 Office E&M - Established | Office | 52 | 37 | $94.93 | $4,936 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 47 | 36 | $11.73 | $551 |
| 99215 Office E&M - Established | Office | 39 | 32 | $124.41 | $4,852 |
By year: 2022 $80K for 12,226 services; 2023 $93K for 13,783 services; 2024 $70K for 10,763 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas Guttuso prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 780 prescriptions and refills. In total Thomas Guttuso wrote 2,346 Medicare prescriptions that cost $299K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 780 | 1,587 | 172 | $63K |
| Gabapentin Generic | 166 | 238 | 37 | $2,370 |
| Amantadine Amantadine Hcl | 144 | 218 | 31 | $5,584 |
| Donepezil Hcl Generic | 133 | 286 | 35 | $1,536 |
| Rasagiline Mesylate Generic | 129 | 235 | 22 | $29K |
| Selegiline Hcl Generic | 92 | 196 | 20 | $10K |
| Primidone Generic | 84 | 175 | 19 | $3,079 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 72 | 138 | 18 | $2,068 |
| Paroxetine Hcl Generic | 61 | 133 | 16 | $765 |
| Lithium Carbonate Generic | 57 | 112 | 13 | $1,034 |
| Fludrocortisone Acetate Generic | 56 | 100 | 13 | $3,175 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 54 | 114 | 15 | $3,448 |
| Quetiapine Fumarate Generic | 54 | 83 | 12 | $986 |
| Propranolol Hcl Er Propranolol Hcl | 49 | 95 | Under 11 | $2,180 |
| Nortriptyline Hcl Generic | 34 | 58 | Under 11 | $668 |
Brand drugs: 120 claims; generic drugs: 2,226 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas Guttuso $235 ($235 in general payments such as food, travel and fees) from 5 companies. The largest payer was MDD US Operations, LLC with $119.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.